bioRxiv

Human cell types recovered differently after partial reprogramming

Experiments in human cells found that lower DNA-based age estimates did not necessarily accompany recovery of specialized identity and function.

Paper by K. Washizu, X. Wang, J. M. Draper, S. Yamanaka, A. Kunitomi · Gladstone Institute of Cardiovascular Disease
Closely fitted vessel-lining cells sit beside loose cells, beneath a fibroblast tangled in fibers and an immune cell breaking apart a target.
Studied:
Preprint: experiments in human cells
In the record:
The 6th paper on partial reprogramming with results in people; 172 on record in all. Its result on epigenetic age agrees with all 5 other findings on record.

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

Primary human fibroblasts (connective-tissue cells), cytotoxic T cells (immune cells that kill other cells) and aortic endothelial cells (which line the aorta) underwent partial reprogramming in laboratory experiments. Researchers isolated intermediate stages, then tracked recovery after withdrawing reprogramming factors—proteins that push cells toward a less specialized state.

Fibroblasts kept a lower DNA methylation age—an age estimate based on chemical marks on DNA—but retained tissue-remodeling changes and did not fully recover their ability to multiply. T cells recovered only from shallow reprogramming, with enhanced immune function. Endothelial cells rapidly recovered their specialized identity, kept a lower methylation age and markedly improved their function as blood-vessel cells.

Why it matters

Attempts to change age-related cell features must also preserve cells’ specialized roles. The authors conclude that the balance between rejuvenation and recovery needs to be optimized for each cell type.

Caveats

Experiments in isolated human cells leave open how these cells would recover and function within a person. The work is a preprint and has not been peer-reviewed.

Comments

Be the first to comment.

The paper

Partial reprogramming reveals lineage-specific uncoupling of rejuvenation, function, and recoverability in human cells

K. Washizu, X. Wang, J. M. Draper, S. Yamanaka, A. Kunitomi

Gladstone Institute of Cardiovascular Disease

bioRxiv, Nov 12, 2026, Open access, CC BY-NC-ND, Preprint, not yet peer-reviewed

doi.org/10.64898/2026.11.09.764947